Quantum Computing Turns to Q3 Net Loss of $15.15 Million; Q3 Revenue Rises to $9.5 Million

• Quantum Computing swung to a third-quarter 2026 net loss of $15.15 million from a year-earlier profit.
• Revenue rose to $9.5 million, primarily driven by businesses acquired during the first half of 2026.
• Operating expenses more than doubled year over year to $29.01 million, primarily due to higher personnel expenses and expanded activities.
• Quarter-end cash, cash equivalents, investments and accrued interest totaled approximately $1.3 billion, while contract backlog reached $39.1 million.
• A commercial agreement with INmune Bio marked its first pharmaceutical and biotechnology customer, applying quantum optimization technology to clinical and biomedical data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Computing Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611091605PR_NEWS_USPR_____PH92923) on November 09, 2026, and is solely responsible for the information contained therein.